A novel molecular assay to discriminate transcriptional effects caused by xenoestrogens

Molecular and Cellular Endocrinology

Volumn 276, Issue 1-2, 2007, Pages 45-54

  Koohi, Mohammad Kazem ^a   Walther, Norbert ^a   Ivell, Richard ^b  

^a UNIVERSITY OF HAMBURG   (Germany)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Estrogen receptor; Oxytocin gene; Phytoestrogen; Xenoestrogen

Indexed keywords

8P NARINGENIN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; GENISTEIN; NARINGENIN; OXYTOCIN; PHYTOESTROGEN; RESVERATROL; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; DRUG MECHANISM; ESTROGEN ACTIVITY; ESTROGEN RESPONSIVE ELEMENT; HORMONE ACTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR BINDING;

ANIMALS; BIOLOGICAL ASSAY; CATIONS, DIVALENT; CATTLE; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGENS; FLAVANONES; GENISTEIN; HUMANS; MUTANT PROTEINS; PHYTOESTROGENS; PROMOTER REGIONS (GENETICS); RECEPTORS, ESTROGEN; STILBENES; TRANSCRIPTION, GENETIC; XENOBIOTICS;

EID: 34548317132     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2007.06.008     Document Type: Article

References (30)

1. Baker V.A. Endocrine disruptors-testing strategies to assess human hazard. Toxicol. In Vitro 15 (2001) 413-419
2. Barnes S., Boersma B., Patel R., Kirk M., Darley-Usmar V.M., Kim H., and Xu J. Isoflavonoids and chronic disease: mechanisms of action. Biofactors 12 (2000) 209-215
3. Bovee T.F., Helsdingen R.J., Rietjens I.M., Keijer J., and Hoogenboom R.L. Rapid yeast estrogen bioassays stably expressing human estrogen receptors alpha and beta, and green fluorescent protein: a comparison of different compounds with both receptor types. J. Steroid Biochem. Mol. Biol. 91 (2004) 99-109
4. Filardo E.J., and Thomas P. GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release. Trends Endocrinol. Metab. 16 (2005) 362-367
5. Gadal F., Starzec A., Bozic C., Pillot-Brochet C., Malinge S., Ozanne V., Vicenzi J., Buffat L., Perret G., Iris F., and Crepin M. Integrative analysis of gene expression patterns predicts specific modulations of defined cell functions by estrogen and tamoxifen in MCF7 breast cancer cells. J. Mol. Endocrinol. 34 (2005) 61-75
6. Glidewell-Kenney C., Weiss J., Lee E.J., Pillai S., Ishikawa T., Ariazi E.A., and Jameson J.L. ERE-independent ERα target genes differentially expressed in human breast tumors. Mol. Cell. Endocrinol. 245 (2005) 53-59
7. Guillette L.J. Endocrine disrupting contaminants-beyond the dogma. Environ. Health Perspect. 114 Suppl. 1 (2006) 9-12
8. Harris D.M., Besselink E., Henning S.M., Go V.L.W., and Heber D. Phytoestrogens induce differential estrogen receptor alpha- or beta-mediated responses in transfected breast cancer cells. Exp. Biol. Med. 230 (2005) 558-568
9. Jorgensen M., Hummel R., Bevort M., Andersson A.M., Skakkebaek N.E., and Leffers H. Detection of oestrogenic chemicals by assessing the expression level of oestrogen regulated genes. APMIS 106 (1998) 245-251
10. Ko W.C., Shih C.M., Lai Y.H., Chen J.H., and Huang H.L. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships. Biochem. Pharmacol. 68 (2004) 2087-2094
11. Koohi M.K., Ivell R., and Walther N. Transcriptional activation of the oxytocin promoter by oestrogens uses a novel non-classical mechanism of oestrogen receptor action. J. Neuroendocrinol. 17 (2005) 197-207
12. Lee Y.R., Park J., Yu H.N., Kim J.S., Youn H.J., and Jung S.H. Up-regulation of PI3K/Akt signalling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells. Biochem. Biophys. Res. Commun. 336 (2005) 1221-1226
13. Matthiessen P., and Sumter J.P. Effects of estrogenic substances in the aquatic environment. EXS 86 (1998) 319-335
14. Predki P.F., and Sarkar B. Effect of replacement of zinc finger zinc on estrogen-receptor DNA interactions. J. Biol. Chem. 267 (1992) 5842-5846
15. Pugazhendhi D., Sadler A.J., and Darbre P.D. Comparison of the global gene expression profiles produced by methylparaben, n-butylparaben and 17β-estradiol in MCF7 human breast cancer cells. J. Appl. Toxicol. 27 (2007) 67-77
16. Ruppert S., Scherer G., and Schutz G. Recent gene conversion involving bovine vasopressin and oxytocin precursor genes suggested by nucleotide sequence. Nature 308 (1984) 554-557
17. Safe S., and Papineni S. The role of xenoestrogenic compounds in the development of breast cancer. Trends Pharmacol. Sci. 27 (2006) 447-454
18. Schaefer O., Humpel M., Fritzemeier K.H., Bohlmann R., and Schleuning W.D. 8-Prenyl-naringenin is a potent ERalpha selective phytoestrogen present in hops and beer. J. Steroid Biochem. Mol. Biol. 84 (2003) 359-360
19. Shioda T., Chesnes J., Coser K.R., Zou L., Hur J., Dean K.L., Sonnenschein C., Soto A.M., and Isselbacher K.J. Importance of dosage standardization for interpreting transcriptomal signature profiles: evidence from studies of xenoestrogens. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 12033-12038
20. Signorelli P., and Ghidoni R. Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J. Nutr. Biochem. 16 (2005) 449-466
21. Silva E., Lopez-Espinosa M.J., Molina-Molina J.M., Fernandez M., Olea N., and Kortenkamp A. Lack of activity of cadmium in in vitro estrogenicity assays. Toxicol. Appl. Pharmacol. 216 (2006) 20-28
22. Song R.X.D., Zhang Z., and Santen R.J. Estrogen rapid action via protein complex formation involving ERα and Src. Trends Endocrinol. Metab. 16 (2005) 347-353
23. Stedronsky K., Telgmann R., Tillmann G., Walther N., and Ivell R. The affinity and activity of the multiple hormone response element in the proximal promoter of the human oxytocin gene. J. Neuroendocrinol. 14 (2002) 472-485
24. Stoica A., Katzenellenbogen B., and Martin M.B. Activation of estrogen receptor-α by the heavy metal cadmium. Mol. Endocrinol. 14 (2000) 545-553
25. Sukocheva O.A., Wang L., Albanese N., Pitson S.M., Vadas M.A., and Xia P. Sphingosine kinase transmits estrogen signalling in human breast cancer cells. Mol. Endocrinol. 17 (2003) 2002-2012
26. Walther N., Lioutas C., Tillmann G., and Ivell R. Cloning of bovine estrogen receptor beta (ERβ): expression of novel deleted isoforms in reproductive tissues. Mol. Cell. Endocrinol. 152 (1999) 37-45
27. Wang W., Dong L., Saville B., and Safe S. Transcriptional activation of E2F1 gene expression by 17beta-estradiol in MCF-7 cells is regulated by NF-Y-Sp1/estrogen receptor interactions. Mol. Endocrinol. 13 (1999) 1373-1387
28. Webb P., Lopez G.N., Uht R.M., and Kushner P.J. Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol. Endocrinol. 9 (1995) 443-456
29. Wehrenberg U., Ivell R., Jansen M., von Goedecke S., and Walther N. Two orphan receptors binding to a common site are involved in the regulation of the oxytocin gene in the bovine ovary. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 1440-1444
30. Zhang S., Li X., Burghardt R., Smith III R., and Safe S.H. Role of estrogen receptor (ER) alpha in insulin-like growth factor (IGF)-1-induced responses in MCF7 breast cancer cells. J. Mol. Endocrinol. 35 (2005) 433-447